2022 / 01

Next Paper
DOI: 10.24075/brsmu.2022.002

ORIGINAL RESEARCH

Visual analysis of nigrosome-1 in the differential diagnosis of Parkinson's disease and essential tremor

Moskalenko AN, Filatov AS, Fedotova EYu, Konovalov RN, Illarioshkin SN
About authors

Research Center of Neurology, Moscow, Russia

Correspondence should be addressed: Anna N. Moskalenko
Volokolamskoe sh., 80, Moscow, 125367, Russia; ur.relbmar@nrek_kin_anna

About paper

Author contribution: Moskalenko AN — clinical assessment, data acquisition and interpretation, literature analysis, manuscript preparation; Filatov AS — data analysis and interpretation, manuscript preparation; Konovalov RN — data analysis and interpretation, study planning and supervision; Fedotova EYu, Illarioshkin SN — study planning and supervision.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Center of Neurology (Protocol № 2–5/20 dated March 18, 2020). Informed consent was obtained from all study participants.

Received: 2021-12-22 Accepted: 2022-01-18 Published online: 2022-01-31
|
  1. Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020; 27 (1): 27–42. DOI: 10.1111/ene.14108. Epub 2019 Nov 27. PMID: 31631455.
  2. Sepúlveda Soto MC, Fasano A. Essential tremor: New advances. Clin Park Relat Disord. 2019; 3: 100031. DOI: 10.1016/j.prdoa.2019.100031. PMID: 34316617; PMCID: PMC8298793.
  3. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30 (12): 1591–601. DOI: 10.1002/mds.26424. PMID: 26474316.
  4. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017; 18 (7): 435–50. DOI: 10.1038/nrn.2017.62. Epub 2017. Erratum in: Nat Rev Neurosci. 2017; 18 (8): 509. PMID: 28592904.
  5. Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord. 2018; 33 (1): 75–87. DOI: 10.1002/mds.27121. Epub 2017 Nov 30. PMID: 29193359.
  6. Brooks DJ. Technology insight: imaging neurodegeneration in Parkinson's disease. Nat Clin Pract Neurol. 2008; 4 (5): 267–77. DOI: 10.1038/ncpneuro0773. Epub 2008. PMID: 18382437.
  7. Tao A, Chen G, Mao Z, Gao H, Deng Y, Xu R. Essential tremor vs idiopathic Parkinson disease: Utility of transcranial sonography. Medicine (Baltimore). 2020; 99 (20): e20028. DOI: 10.1097/ MD.0000000000020028. PMID: 32443307.
  8. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D (28K) immunohistochemistry. Brain. 1999; 122 (Pt 8): 1421–36. DOI: 10.1093/brain/122.8.1421. PMID: 10430829.
  9. Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, Bajaj N, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology. 2013; 81 (6): 534–40. DOI: 10.1212/WNL.0b013e31829e6fd2. Epub 2013 Jul 10. PMID: 23843466.
  10. Cheng Z, He N, Huang P, Li Y, Tang R, Sethi SK, et al. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease. Neuroimage Clin. 2020; 25: 102103. DOI: 10.1016/j.nicl.2019.102103. Epub 2019 Nov 20. PMID: 31869769.
  11. Reiter E, Mueller C, Pinter B, Krismer F, Scherfler C, Esterhammer R, et al. Dorsolateral nigral hyperintensity on 3.0T susceptibilityweighted imaging in neurodegenerative Parkinsonism. Mov Disord. 2015; 30 (8): 1068–76. DOI: 10.1002/mds.26171. Epub 2015 Mar 15. PMID: 25773707.
  12. Mavroudis I, Petridis F, Kazis D. Neuroimaging and neuropathological findings in essential tremor. Acta Neurol Scand. 2019; 139 (6): 491–6. DOI: 10.1111/ane.13101. Epub 2019. PMID: 30977113.
  13. Jin L, Wang J, Wang C, Lian D, Zhou Y, Zhang Y, et al. Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease. Front Neurol. 2019 Feb 12; 10: 100. DOI: 10.3389/fneur.2019.00100. PMID: 30809189.
  14. Perez Akly MS, Stefani CV, Ciancaglini L, Bestoso JS, Funes JA, Bauso DJ et al. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor. Neuroradiol J. 2019 Dec; 32 (6): 395–400. DOI: 10.1177/1971400919853787. Epub 2019 May 31. PMID: 31149866.
  15. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. 1999; 122 (Pt 8): 1437–48. DOI: 10.1093/brain/122.8.1437. PMID: 10430830.
  16. Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP. The 'swallow tail' appearance of the healthy nigrosome — a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One. 2014; 9 (4): e93814. DOI: 10.1371/journal.pone.0093814. PMID: 24710392.
  17. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med. 2004; 52 (3): 612–8. DOI: 10.1002/mrm.20198. PMID: 15334582.
  18. Gao P, Zhou PY, Li G, Zhang GB, Wang PQ, Liu JZ, et al. Visualization of nigrosomes-1 in 3T MR susceptibility weighted imaging and its absence in diagnosing Parkinson's disease. Eur Rev Med Pharmacol Sci. 2015; 19 (23): 4603–9. PMID: 26698258.
  19. Pavese N, Tai YF. Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism. Mov Disord Clin Pract. 2018; 5 (2): 131–40. DOI: 10.1002/mdc3.12590. PMID: 30363419.
  20. Lehéricy S, Bardinet E, Poupon C, Vidailhet M, François C. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. 2014; 29 (13): 1574–81. DOI: 10.1002/mds.26043. Epub 2014. PMID: 25308960.
  21. Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell. 2019; 18 (6): e13031. DOI: 10.1111/acel.13031. Epub 2019 Aug 20. PMID: 31432604.
  22. Chau MT, Todd G, Wilcox R, Agzarian M, Bezak E. Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2020; 78: 12–20. DOI: 10.1016/j.parkreldis.2020.07.002. Epub 2020 Jul 7. PMID: 32668370.